DMAA
DRUGS MADE IN AMERICA ACQUISITION CORP.
Company Overview
Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.
SectorFinancial Services
IndustryShell Companies
Market Cap$264.0M
Last DividendNone
Employees2
CEORoger Bendelac
Websitehttps://dmaacorp.com
Valuation
Current Price$10.88
Fair Value?$000.00
Valuation?No valuation
Current PE ?36.27
Hist. PE ?N/Aⓘ
EPS (TTM) ?0.3
Forward EPS Growth ?—
Historical Growth ?-2866.77%
Equity, FCF, Long Term Debt, Net Profit, and Shares Outstanding history charts are available on the Pro plan for just $9.99/month.Sign in to unlock Pro
Price?
EPS?
Revenue?
Equity?
ProAvailable on the Pro plan
Free Cash Flow?
ProAvailable on the Pro plan
Long Term Debt?
ProAvailable on the Pro plan
Net Profit?
ProAvailable on the Pro plan
Shares Outstanding?
ProAvailable on the Pro plan
Last updated: 10/23/2026, 11:16:55 PM